Article
India's Biocon Biologics launches biosimilar for AbbVie's Humira in US
Rating:
0.0
Views:
94
Likes:
1
Library:
1
India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster rheumatoid arthritis drug Humira in the United States.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value